Runx1/AML1 in normal and abnormal hematopoiesis

Area of Science:

• Hematopoiesis and Molecular Biology
• Cancer Genetics
• Transcription Factor Regulation

Background:

• Runx1/AML1 is a Runt family transcription factor vital for normal hematopoiesis.
• It functions by forming heterodimers and interacting with coactivators and corepressors to regulate gene transcription.
• Runx1 is essential for fetal hematopoiesis and adult development of megakaryocytes, T-lymphocytes, and B-lymphocytes.

Purpose of the Study:

• To review the critical role of Runx1 in hematopoiesis.
• To discuss the involvement of Runx1 in leukemia-associated chromosomal translocations and the molecular mechanisms of leukemogenesis.
• To highlight the significance of Runx1 protein structure and dosage in maintaining normal hematopoiesis.

Main Methods:

• Literature review of Runx1 function and its role in hematological malignancies.
• Analysis of molecular mechanisms involving Runx1 in gene transcription regulation.
• Examination of data from mutant mouse models expressing Runx1 fusion proteins.

Main Results:

• Runx1 regulates gene transcription through interactions with coactivators (p300, CREB-binding protein) and corepressors (mSin3A, TLE, histone deacetylases).
• Chromosomal translocations involving Runx1 are identified in various leukemias, producing fusion proteins.
• Expression of fusion proteins alone is insufficient for leukemogenesis, suggesting additional events are required.

Conclusions:

• The correct protein structure and precise dosage of Runx1 are essential for normal hematopoiesis.
• Disruptions in Runx1 function, through mutations or fusion proteins, are implicated in familial platelet disorder with propensity for acute myeloid leukemia (FPD/AML) and AML-M0.
• Further research into Runx1 regulation and its role in leukemia is warranted.